Taj Pharmaceuticals as Manufacturer of Calcium Gluconate Injection USP 1g/10ml Calcium Gluconate Injection USP 1g/10ml manufacturer in India {Taj Pharmaceuticals}; best quality supplier and exporter of Calcium Gluconate Injection USP 1g/10ml Taj Pharmaceuticals manufactures a wide range of pharmaceuticals formulation involving Tablets / Capsules / Injections and Orals. Taj Pharma India teamhas an excellent expertise in manufacturing and export of Calcium Gluconate Injection USP 1g/10ml. Taj Pharmaceuticals places its main business as a Pharmaceuticals manufacturing and exports of generic drug supply of Calcium Gluconate Injection USP 1g/10ml; primarily of pharmaceuticals preparations known as Calcium Gluconate Injection USP 1g/10ml; as well as more than 100+ generic equivalent drug. Taj Pharmaceuticals has performed these business activities related to exports of Calcium Gluconate Injection USP 1g/10mlfor major foreign-affiliated pharmaceutical import companies, ministry of health, tenders etc. and have enjoyed the full confidence of these companies, instructions and governments. Taj Pharma Group Under close cooperation between the formulation manufacturing division, active ingredient divisionand the technology development division for major generic formulations such as Calcium Gluconate Injection USP 1g/10ml;at Taj Pharma we will appropriately meet diverse needs for Calcium Gluconate Injection USP 1g/10ml export manufacturing in a wide range of activities from investigation of possible formulations of Calcium Gluconate Injection USP 1g/10ml, formulation development, making applications to the international regulatory authorities for marketing approval, validation of Calcium Gluconate Injection USP 1g/10mlthrough to manufacturing scale production at our cGMP compliant manufacturing units of Taj Pharmaceuticals under the umbrella of Taj Pharma Group. We at Taj Pharmaintend to make our manufacturing systems comply with the requirements of the FDA (cGMP) such that pilot plant scale production of products in the stage of clinical development or for use in clinical studies, as well as manufacture of products in small lots are practicable to ensure a highly stable pharmaceuticals formulations of generic equivalent and bio-similar products. We conduct extensive bio-similar and bio-equivalency studies for all our formations